Literature DB >> 11746624

Serum leptin concentrations and satiety in Parkinson's disease patients with and without weight loss.

V G Evidente1, J N Caviness, C H Adler, K A Gwinn-Hardy, R E Pratley.   

Abstract

We compared serum leptin and satiety measures in 18 Parkinson's disease (PD) patients with unintended weight loss (WL) and 18 PD patients whose weight was stable (WS). Mean serum leptin concentrations tended to be lower in WL than WS patients, but this did not reach statistical significance. Body mass index correlated with serum leptin concentrations. Ratings of hunger, satiety, fullness, and thirst did not differ between groups. However, the mean sensation of fullness before meals correlated with serum leptin in the entire cohort of patients, particularly in the WL group. The results indicate that unintended weight loss in PD patients is unlikely to be due to abnormal serum leptin concentrations. Copyright 2001 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746624     DOI: 10.1002/mds.1165

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

1.  Serum Leptin Levels and Cognition in Parkinson's Disease Patients.

Authors:  Gülay Kenangil; Betül Özdilek
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

Review 2.  Weight loss in Parkinson's disease.

Authors:  Kenichi Kashihara
Journal:  J Neurol       Date:  2006-12       Impact factor: 4.849

Review 3.  Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders.

Authors:  Huan Cai; Wei-na Cong; Sunggoan Ji; Sarah Rothman; Stuart Maudsley; Bronwen Martin
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

Review 4.  Food for Thought: Leptin and Hippocampal Synaptic Function.

Authors:  Jenni Harvey
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

5.  Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.

Authors:  Sarah M Rothman; Kathleen J Griffioen; Kenneth W Fishbein; Richard G Spencer; Sokratis Makrogiannis; Wei-Na Cong; Bronwen Martin; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2013-10-22       Impact factor: 4.673

6.  Serum leptin concentrations in Turkish Parkinson's disease population.

Authors:  Betul Ozdilek; Gulay Kenangil
Journal:  Parkinsons Dis       Date:  2014-04-28

Review 7.  Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects.

Authors:  Kai Ma; Nian Xiong; Yan Shen; Chao Han; Ling Liu; Guoxin Zhang; Luxi Wang; Shiyi Guo; Xingfang Guo; Yun Xia; Fang Wan; Jinsha Huang; Zhicheng Lin; Tao Wang
Journal:  Front Aging Neurosci       Date:  2018-01-19       Impact factor: 5.750

8.  Serum leptin levels in Iranian patients with Parkinson's disease.

Authors:  Mehri Salari; Mahdi Barzegar; Masoud Etemadifar; Omid Mirmosayyeb
Journal:  Iran J Neurol       Date:  2018-04-04

9.  The Relation of Circulating Levels of Leptin with Cognition in Patients with Alzheimer's Disease.

Authors:  Mustafa Ülker; Gülay Kenangil
Journal:  Noro Psikiyatr Ars       Date:  2018-06-05       Impact factor: 1.339

Review 10.  The role of leptin in central nervous system diseases.

Authors:  Xiao-Mei Li; Hai-Jing Yan; Yi-Shan Guo; Dong Wang
Journal:  Neuroreport       Date:  2016-03-23       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.